Skip to content

Evaluation of immune status before and after splenectomy in patients with immune thrombocytopenia

Evaluation of immune status before and after splenectomy in patients with immune thrombocytopenia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019304
Enrollment
Unknown
Registered
2018-11-04
Start date
2018-11-10
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immune thrombocytopenia

Interventions

before splenectomy:splenectomy
after splenectomy:splenectomy

Sponsors

Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 60 years old, male or female; 2. Conform to the diagnostic criteria of ITP: (1) decreased platelet counts in many laboratory tests; (2) Without splenmegaly; (3) Elevated or normal number of megakaryocytes in the bone morrow examination with dysmaturity; (4) With exception of other secondary thrombocytopenic purpura; 3. Needed splenectomy; 4. People who are willing to sign the informed consent voluntarily and follow the research program.

Exclusion criteria

Exclusion criteria: 1. Secondary thrombocytopenic purpura; 2. Patients with poor compliance; 3. Researchers believe that patients should not participate in the test of any other condition.

Design outcomes

Primary

MeasureTime frame
Subgroup of Th cells in Peripheral blood and spleen;Ratio of Treg, Ts, regulatory b cells;The expression of FcRI, FcRII, FcRIII, FcRIIb on monocyte/macrophage in Peripheral blood and spleen;Expression of relevant inflammatory factors in plasma;B cell proliferation, ratio of plasmocyte, the content of IgG/IgA in vitro culture;

Secondary

MeasureTime frame
Killing of platelets by CD8+ T cells in spleen;Phagocytosis on platelet by spleen macrophages;

Countries

China

Contacts

Public ContactZhang Lei

Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College

zhanglei1@ihcams.ac.cn+86 022-23909009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026